Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration

a Meta-analysis

Yu Qin, Jiang Yue Zhao, Chun Shu Pan, Xue Fei He, Xiao Jie Min, Mingwu Wang, Qi Chang Yan, Di Wu, Jing Li, Xin Wei Wu, Jin Song Zhang

Research output: Contribution to journalArticle

Abstract

AIM: To explore the association between the polymorphism rs2511989 in the classical pathway geneSERPING1 (C1 inhibitor) and age-related macular degeneration (AMD). METHODS: A random-effect Meta-analysis was performed. An electronic search was done in CNKI, PubMed, the Cochrane Collaboration's Database, Embase, and the ISI Web of Knowledge. Odds ratios (OR) and their 95% confidence interval (CI) were calculated to assess the strength of association between SERPING1 rs2511989 polymorphism and AMD susceptibility. Heterogeneity, sensitivity analysis and publication bias were also tested. RESULTS: A total of 15 case-control studies with 8657 cases and 5393 controls were finally included in this Meta-analysis. There was no significant association between SERPING1 and AMD in all genetic models. (Dominant model: OR=0.960, 95%CI: 0.918-1.003, P=0.009; recessive model: OR=0.898, 95%CI: 0.791-1.019, P=0.035; homozygote model: OR=0.881, 95%CI: 0.770-1.008, P=0.003; heterozygote model: OR=0.962, 95%CI: 0.917-1.010, P=0.050). However, the associations between SERPING1 and neovascular AMD were significant in three models (dominant model: OR=0.691, 95%CI: 0.547-0.872; homozygote model: OR=0.661, 95%CI: 0.450-0.971; heterozygote model: OR=0.754, 95%CI: 0.589-0.964). Subgroup analysis by ethnicity and country did not find significant association between rs2511989 polymorphism and AMD susceptibility. CONCLUSION: SERPING1 rs2511989 does not associates with AMD generally but may associate with neovascular AMD. More studies are required to verify the hypothesis.

Original languageEnglish (US)
Pages (from-to)944-949
Number of pages6
JournalInternational Eye Science
Volume15
Issue number6
DOIs
StatePublished - Jun 8 2015

Fingerprint

Macular Degeneration
Meta-Analysis
Odds Ratio
Confidence Intervals
Homozygote
Heterozygote
Publication Bias
Genetic Models
PubMed
Case-Control Studies
Databases

Keywords

  • Age-related macular degeneration
  • Meta-analysis
  • Polymorphism
  • SERPING1

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration : a Meta-analysis. / Qin, Yu; Zhao, Jiang Yue; Pan, Chun Shu; He, Xue Fei; Min, Xiao Jie; Wang, Mingwu; Yan, Qi Chang; Wu, Di; Li, Jing; Wu, Xin Wei; Zhang, Jin Song.

In: International Eye Science, Vol. 15, No. 6, 08.06.2015, p. 944-949.

Research output: Contribution to journalArticle

Qin, Y, Zhao, JY, Pan, CS, He, XF, Min, XJ, Wang, M, Yan, QC, Wu, D, Li, J, Wu, XW & Zhang, JS 2015, 'Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration: a Meta-analysis', International Eye Science, vol. 15, no. 6, pp. 944-949. https://doi.org/10.3980/j.issn.1672-5123.2015.6.02
Qin, Yu ; Zhao, Jiang Yue ; Pan, Chun Shu ; He, Xue Fei ; Min, Xiao Jie ; Wang, Mingwu ; Yan, Qi Chang ; Wu, Di ; Li, Jing ; Wu, Xin Wei ; Zhang, Jin Song. / Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration : a Meta-analysis. In: International Eye Science. 2015 ; Vol. 15, No. 6. pp. 944-949.
@article{80607bdd4ca24749ad332972a5b5dbea,
title = "Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration: a Meta-analysis",
abstract = "AIM: To explore the association between the polymorphism rs2511989 in the classical pathway geneSERPING1 (C1 inhibitor) and age-related macular degeneration (AMD). METHODS: A random-effect Meta-analysis was performed. An electronic search was done in CNKI, PubMed, the Cochrane Collaboration's Database, Embase, and the ISI Web of Knowledge. Odds ratios (OR) and their 95{\%} confidence interval (CI) were calculated to assess the strength of association between SERPING1 rs2511989 polymorphism and AMD susceptibility. Heterogeneity, sensitivity analysis and publication bias were also tested. RESULTS: A total of 15 case-control studies with 8657 cases and 5393 controls were finally included in this Meta-analysis. There was no significant association between SERPING1 and AMD in all genetic models. (Dominant model: OR=0.960, 95{\%}CI: 0.918-1.003, P=0.009; recessive model: OR=0.898, 95{\%}CI: 0.791-1.019, P=0.035; homozygote model: OR=0.881, 95{\%}CI: 0.770-1.008, P=0.003; heterozygote model: OR=0.962, 95{\%}CI: 0.917-1.010, P=0.050). However, the associations between SERPING1 and neovascular AMD were significant in three models (dominant model: OR=0.691, 95{\%}CI: 0.547-0.872; homozygote model: OR=0.661, 95{\%}CI: 0.450-0.971; heterozygote model: OR=0.754, 95{\%}CI: 0.589-0.964). Subgroup analysis by ethnicity and country did not find significant association between rs2511989 polymorphism and AMD susceptibility. CONCLUSION: SERPING1 rs2511989 does not associates with AMD generally but may associate with neovascular AMD. More studies are required to verify the hypothesis.",
keywords = "Age-related macular degeneration, Meta-analysis, Polymorphism, SERPING1",
author = "Yu Qin and Zhao, {Jiang Yue} and Pan, {Chun Shu} and He, {Xue Fei} and Min, {Xiao Jie} and Mingwu Wang and Yan, {Qi Chang} and Di Wu and Jing Li and Wu, {Xin Wei} and Zhang, {Jin Song}",
year = "2015",
month = "6",
day = "8",
doi = "10.3980/j.issn.1672-5123.2015.6.02",
language = "English (US)",
volume = "15",
pages = "944--949",
journal = "International Eye Science",
issn = "1672-5123",
publisher = "Press of International Journal of Ophthalmology",
number = "6",

}

TY - JOUR

T1 - Geneticpolymorphism of SERPING1 rs2511989 and age-related macular degeneration

T2 - a Meta-analysis

AU - Qin, Yu

AU - Zhao, Jiang Yue

AU - Pan, Chun Shu

AU - He, Xue Fei

AU - Min, Xiao Jie

AU - Wang, Mingwu

AU - Yan, Qi Chang

AU - Wu, Di

AU - Li, Jing

AU - Wu, Xin Wei

AU - Zhang, Jin Song

PY - 2015/6/8

Y1 - 2015/6/8

N2 - AIM: To explore the association between the polymorphism rs2511989 in the classical pathway geneSERPING1 (C1 inhibitor) and age-related macular degeneration (AMD). METHODS: A random-effect Meta-analysis was performed. An electronic search was done in CNKI, PubMed, the Cochrane Collaboration's Database, Embase, and the ISI Web of Knowledge. Odds ratios (OR) and their 95% confidence interval (CI) were calculated to assess the strength of association between SERPING1 rs2511989 polymorphism and AMD susceptibility. Heterogeneity, sensitivity analysis and publication bias were also tested. RESULTS: A total of 15 case-control studies with 8657 cases and 5393 controls were finally included in this Meta-analysis. There was no significant association between SERPING1 and AMD in all genetic models. (Dominant model: OR=0.960, 95%CI: 0.918-1.003, P=0.009; recessive model: OR=0.898, 95%CI: 0.791-1.019, P=0.035; homozygote model: OR=0.881, 95%CI: 0.770-1.008, P=0.003; heterozygote model: OR=0.962, 95%CI: 0.917-1.010, P=0.050). However, the associations between SERPING1 and neovascular AMD were significant in three models (dominant model: OR=0.691, 95%CI: 0.547-0.872; homozygote model: OR=0.661, 95%CI: 0.450-0.971; heterozygote model: OR=0.754, 95%CI: 0.589-0.964). Subgroup analysis by ethnicity and country did not find significant association between rs2511989 polymorphism and AMD susceptibility. CONCLUSION: SERPING1 rs2511989 does not associates with AMD generally but may associate with neovascular AMD. More studies are required to verify the hypothesis.

AB - AIM: To explore the association between the polymorphism rs2511989 in the classical pathway geneSERPING1 (C1 inhibitor) and age-related macular degeneration (AMD). METHODS: A random-effect Meta-analysis was performed. An electronic search was done in CNKI, PubMed, the Cochrane Collaboration's Database, Embase, and the ISI Web of Knowledge. Odds ratios (OR) and their 95% confidence interval (CI) were calculated to assess the strength of association between SERPING1 rs2511989 polymorphism and AMD susceptibility. Heterogeneity, sensitivity analysis and publication bias were also tested. RESULTS: A total of 15 case-control studies with 8657 cases and 5393 controls were finally included in this Meta-analysis. There was no significant association between SERPING1 and AMD in all genetic models. (Dominant model: OR=0.960, 95%CI: 0.918-1.003, P=0.009; recessive model: OR=0.898, 95%CI: 0.791-1.019, P=0.035; homozygote model: OR=0.881, 95%CI: 0.770-1.008, P=0.003; heterozygote model: OR=0.962, 95%CI: 0.917-1.010, P=0.050). However, the associations between SERPING1 and neovascular AMD were significant in three models (dominant model: OR=0.691, 95%CI: 0.547-0.872; homozygote model: OR=0.661, 95%CI: 0.450-0.971; heterozygote model: OR=0.754, 95%CI: 0.589-0.964). Subgroup analysis by ethnicity and country did not find significant association between rs2511989 polymorphism and AMD susceptibility. CONCLUSION: SERPING1 rs2511989 does not associates with AMD generally but may associate with neovascular AMD. More studies are required to verify the hypothesis.

KW - Age-related macular degeneration

KW - Meta-analysis

KW - Polymorphism

KW - SERPING1

UR - http://www.scopus.com/inward/record.url?scp=84932128476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932128476&partnerID=8YFLogxK

U2 - 10.3980/j.issn.1672-5123.2015.6.02

DO - 10.3980/j.issn.1672-5123.2015.6.02

M3 - Article

VL - 15

SP - 944

EP - 949

JO - International Eye Science

JF - International Eye Science

SN - 1672-5123

IS - 6

ER -